These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 11131281)
1. Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells. Kohno M; Ohmori K; Nozaki S; Mizushige K; Yasunari K; Kano H; Minami M; Yoshikawa J Hypertens Res; 2000 Nov; 23(6):677-81. PubMed ID: 11131281 [TBL] [Abstract][Full Text] [Related]
2. Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells. Kohno M; Yokokawa K; Kano H; Yasunari K; Minami M; Hanehira T; Yoshikawa J Hypertension; 1997 Jun; 29(6):1309-13. PubMed ID: 9180634 [TBL] [Abstract][Full Text] [Related]
3. Effect of the endothelin family of peptides on human coronary artery smooth-muscle cell migration. Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Yoshikawa J J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S84-9. PubMed ID: 9595408 [TBL] [Abstract][Full Text] [Related]
4. Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery. Mueck AO; Seeger H; Lippert TH Int J Clin Pharmacol Ther; 1999 Jul; 37(7):365-6. PubMed ID: 10442512 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation. Bruder-Nascimento T; Chinnasamy P; Riascos-Bernal DF; Cau SB; Callera GE; Touyz RM; Tostes RC; Sibinga NE J Mol Cell Cardiol; 2014 Jan; 66():18-26. PubMed ID: 24445059 [TBL] [Abstract][Full Text] [Related]
6. Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells. Sironi L; Calvio AM; Arnaboldi L; Corsini A; Parolari A; de Gasparo M; Tremoli E; Mussoni L Hypertension; 2001 Mar; 37(3):961-6. PubMed ID: 11244025 [TBL] [Abstract][Full Text] [Related]
7. AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns. Clair MJ; Krombach RS; Hendrick JW; Houck WV; Hebbar L; Kribbs SB; Rios G; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG J Card Fail; 1998 Dec; 4(4):311-23. PubMed ID: 9924853 [TBL] [Abstract][Full Text] [Related]
8. Biphasic regulation of Na+-HCO3- cotransporter by angiotensin II type 1A receptor. Horita S; Zheng Y; Hara C; Yamada H; Kunimi M; Taniguchi S; Uwatoko S; Sugaya T; Goto A; Fujita T; Seki G Hypertension; 2002 Nov; 40(5):707-12. PubMed ID: 12411466 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists. Dubey RK; Flammer J; Lüscher TF Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2067-75. PubMed ID: 9761285 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries. Pantev E; Stenman E; Wackenfors A; Edvinsson L; Malmsjö M Eur J Heart Fail; 2002 Dec; 4(6):699-705. PubMed ID: 12453539 [TBL] [Abstract][Full Text] [Related]
11. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748 [TBL] [Abstract][Full Text] [Related]
12. Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARγ activation. Chen HY; Xu Z; Chen LF; Wang W; Fang Q; Yan XW J Cardiovasc Pharmacol; 2012 Jun; 59(6):570-5. PubMed ID: 22392065 [TBL] [Abstract][Full Text] [Related]
14. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Wu L; Iwai M; Nakagami H; Li Z; Chen R; Suzuki J; Akishita M; de Gasparo M; Horiuchi M Circulation; 2001 Nov; 104(22):2716-21. PubMed ID: 11723025 [TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Wu L; Iwai M; Nakagami H; Chen R; Suzuki J; Akishita M; de Gasparo M; Horiuchi M Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):49-54. PubMed ID: 11788460 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Chen K; Mehta JL; Li D; Joseph L; Joseph J Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634 [TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin II on nitric oxide generation in proliferating and quiescent rat coronary microvascular endothelial cells. Bayraktutan U; Ulker S Hypertens Res; 2003 Sep; 26(9):749-57. PubMed ID: 14620932 [TBL] [Abstract][Full Text] [Related]
18. Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Ueda M; Yoshikawa J Circ Res; 1997 Oct; 81(4):585-90. PubMed ID: 9314840 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan. Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA J Hypertens; 2001 Dec; 19(12):2241-50. PubMed ID: 11725169 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists. Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner HR; Burnier M Hypertension; 1999 Mar; 33(3):850-5. PubMed ID: 10082498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]